Press releases, Reports & Disclosures for MBME GROUP Private Joint Stock Company

The Board of Directors of MBME Group PJSC, based in Abu Dhabi, UAE, held a meeting on 29th February 2024. The board approved the audited financial results for the fiscal year ending 31st December 2023, and decided to invite shareholders to the Annual General Assembly on 29th March 2024, subject to the necessary approval from the Ministry of Economy. Other general business matters were also discussed and approved. The board secretary is Paul Mckendry.

The information in this presentation was prepared by MBME Group PJSC and is intended for informational purposes only, without any guarantee of accuracy or completeness. It does not constitute an offer for the sale or purchase of securities and should not be relied upon for any contractual commitments. The information is based on current matters and may change without notice. There is no obligation to update the information or correct any inaccuracies. The document contains forward-looking statements that are not guaranteed and could differ from actual results due to various factors. These statements should not be relied upon as the most likely scenario. The document has not been reviewed by any regulatory authority and may not be stored or reproduced without permission from MBME Group PJSC.

The text is a letter from MBME Group PJSC in Abu Dhabi, UAE to the Disclosure and Compliance Section of the Abu Dhabi Securities Exchange. Dated 12th February 2024, the letter provides a summary of the unaudited preliminary results for the year ended 31st December 2023. The company's audited financial statements for the same period will be disclosed after the approval of the Board of Directors. The letter is signed by Abdelhadi Mohamed, the MD & Group CEO of MBME Group PJSC.

The document is a letter dated 22 December 2023, from MBME Group PJSC. It is addressed to the Disclosure and Compliance Section of the Market Operations Surveillance Department at the Abu Dhabi Securities Exchange. The letter discusses the results of a recent board meeting. Two specific resolutions were highlighted: the appointment of Mr. William Paul Mckendry as the board secretary, and the approval of the budget for the upcoming year (2024). The letter is signed by the MD & Group CEO, Abdelhadi Mohamed.

The MBME Group, located in Villa A14, Marina Village, Abu Dhabi, has announced a Board of Directors meeting scheduled for 22nd December 2023. The meeting will be held at 3:00 pm to discuss and approve the budget for 2024 and the appointment of the board secretary. The information was disclosed by the MD & Group CEO, Abdelhadi Mohamed.

MBME Pay Payment Services Provider, a company of the MBME Group, has entered into an agreement with EITC Financial Services LLC (Du Pay), one of the two main telecom operators in the UAE. The agreement aims to enable Du Pay customers to benefit from the digital services provided by MBME to enhance their satisfaction and keep pace with the digital advancements. This agreement is considered a significant milestone in the evolution of the MBME Group.

MBME Group P.J.S.C. has announced the appointment of Mrs. Briseida Sinaj as the new Group Chief Financial Officer (CFO). Mrs. Sinaj holds a Master’s Degree in Finance Accounting and is a member of the CMA from the International Management Accounting organization. With 15 years of experience across various industries, she has a proven track record in improving financial performance and strategy. She will be working with the existing MBME Executive Management team to ensure the development of the company's plans and continuity of its engagements.

MBME Pay, a payment services provider and part of the MBME Group, has signed an agreement with Axiom Telecom, a large mobile phone retail company. The agreement aims to leverage the digital solutions and comprehensive channels offered by MBME Pay to reach a larger customer base and improve the level of services provided to customers. This partnership is a significant milestone in the evolution of MBME Group. The letter was signed by Abdelhadi Mohamed, MD & Group CEO of MBME Group.